Accordingly, over 98% of currently diagnosed cardiac amyloidosis results from fibrils composed of monoclonal immunoglobulin light chains (AL) or transthyretin (ATTR), either in its hereditary (ATTRv) or acquired (ATTRwt) form [3]. The gene discussed is TTR; the disease is cardiac amyloidosis.